These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 26226848)

  • 21. Oral fluid drug analysis in the age of new psychoactive substances.
    Øiestad EL; Øiestad ÅM; Gjelstad A; Karinen R
    Bioanalysis; 2016 Apr; 8(7):691-710. PubMed ID: 26964619
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bath salts and polyconsumption: in search of drug-drug interactions.
    Lopez-Rodriguez AB; Viveros MP
    Psychopharmacology (Berl); 2019 Mar; 236(3):1001-1014. PubMed ID: 30911791
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Synthetic cannabinoids--the new "legal high" drugs].
    Berkovitz R; Arieli M; Marom E
    Harefuah; 2011 Dec; 150(12):884-7, 937. PubMed ID: 22352277
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New synthetic drugs in addictovigilance.
    Chavant F; Boucher A; Le Boisselier R; Deheul S; Debruyne D
    Therapie; 2015; 70(2):167-89. PubMed ID: 25858573
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Emerging drugs of abuse: clinical and legal considerations.
    Aoun EG; Christopher PP; Ingraham JW
    R I Med J (2013); 2014 Jun; 97(6):41-5. PubMed ID: 24905374
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthetic cathinones: chemistry, pharmacology and toxicology of a new class of designer drugs of abuse marketed as "bath salts" or "plant food".
    Coppola M; Mondola R
    Toxicol Lett; 2012 Jun; 211(2):144-9. PubMed ID: 22459606
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthetic Cannabinoids and Cathinones Cardiotoxicity: Facts and Perspectives.
    Radaelli D; Manfredi A; Zanon M; Fattorini P; Scopetti M; Neri M; Frisoni P; D'Errico S
    Curr Neuropharmacol; 2021; 19(11):2038-2048. PubMed ID: 33845747
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Spice in France: mixed herbs containing synthetic cannabinoids].
    Schlatter J; Chiadmi F; Chariot P
    Ann Biol Clin (Paris); 2012; 70(4):413-22. PubMed ID: 22796613
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Changing Drug Culture: Emerging Drugs of Abuse and Legal Highs.
    Albertson TE; Chenoweth JA; Colby DK; Sutter ME
    FP Essent; 2016 Feb; 441():18-24. PubMed ID: 26881769
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Synthetic cannabinoids: spread, addiction biology & current perspective of personal health hazard].
    Bonnet U; Mahler H
    Fortschr Neurol Psychiatr; 2015 Apr; 83(4):221-31. PubMed ID: 25893495
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Motivations for new psychoactive substance use among regular psychostimulant users in Australia.
    Sutherland R; Bruno R; Peacock A; Lenton S; Matthews A; Salom C; Dietze P; Butler K; Burns L; Barratt MJ
    Int J Drug Policy; 2017 May; 43():23-32. PubMed ID: 28161577
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of first and second generation legal highs for synthetic cannabinoids and synthetic stimulants by ultra-performance liquid chromatography and time of flight mass spectrometry.
    Shanks KG; Dahn T; Behonick G; Terrell A
    J Anal Toxicol; 2012 Jul; 36(6):360-71. PubMed ID: 22586208
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emerging drugs in Europe.
    Papaseit E; Farré M; Schifano F; Torrens M
    Curr Opin Psychiatry; 2014 Jul; 27(4):243-50. PubMed ID: 24840157
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monitoring of herbal mixtures potentially containing synthetic cannabinoids as psychoactive compounds.
    Dresen S; Ferreirós N; Pütz M; Westphal F; Zimmermann R; Auwärter V
    J Mass Spectrom; 2010 Oct; 45(10):1186-94. PubMed ID: 20857386
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical toxicology and management of intoxications with synthetic cathinones ("bath salts").
    Mas-Morey P; Visser MH; Winkelmolen L; Touw DJ
    J Pharm Pract; 2013 Aug; 26(4):353-7. PubMed ID: 23178412
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Beyond THC: The New Generation of Cannabinoid Designer Drugs.
    Fattore L; Fratta W
    Front Behav Neurosci; 2011; 5():60. PubMed ID: 22007163
    [TBL] [Abstract][Full Text] [Related]  

  • 37. From "herbal highs" to the "heroin of cannabis": Exploring the evolving discourse on synthetic cannabinoid use in a Norwegian Internet drug forum.
    Bilgrei OR
    Int J Drug Policy; 2016 Mar; 29():1-8. PubMed ID: 26860324
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Internet highs--seizures after consumption of synthetic cannabinoids purchased online.
    Tofighi B; Lee JD
    J Addict Med; 2012 Sep; 6(3):240-1. PubMed ID: 22824736
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Toxicology of New Psychoactive Substances: Synthetic Cathinones and Phenylethylamines.
    Tyrkkö E; Andersson M; Kronstrand R
    Ther Drug Monit; 2016 Apr; 38(2):190-216. PubMed ID: 26587869
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthetic cathinones: "a khat and mouse game".
    Katz DP; Bhattacharya D; Bhattacharya S; Deruiter J; Clark CR; Suppiramaniam V; Dhanasekaran M
    Toxicol Lett; 2014 Sep; 229(2):349-56. PubMed ID: 24973490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.